Advertisement

Topics

Amplyx brings in $67mm via Series C

15:40 EDT 7 Aug 2017 | Elsevier Business Intelligence

Antifungals developer Amplyx Pharmaceuticals Inc. raised $67mm in its Series C financing led by Sofinnova Venture Partners, w...

Original Article: Amplyx brings in $67mm via Series C

NEXT ARTICLE

More From BioPortfolio on "Amplyx brings in $67mm via Series C"

Quick Search
Advertisement
 

Relevant Topics

Bioscience
Bioscience - any of the sciences that deal with living organisms.  The study of the nature, behavior, and uses of living organisms as applied to biology. Any of the branches of natural science dealing with living things, such as their structure, b...

Clincial Trials
In a clinical trial or interventional study, participants receive specific interventions according to the research plan or protocol created by the investigators. These interventions may be medical products, such as drugs or devices; procedures; or change...